This invention relates to the field of cancer therapy. More particularly,
the invention relates to the treatment of mammary tumor, clinically
manifest mammary tumor (breast cancer) and metastatic mammary tumor by
administration of human Chorionic Gonadotropin (hCG). The treatment
preferably comprises the administration of hCG in conjunction with an
antiestrogen and/or a Type I Interferon.